Dr Mansukh Mandaviya unveils Bharat Biotech intransal COVID vaccine iNCOVACC Ruchika Sharma27 Jan 2023 6:42 AM GMTiNCOVACC is a cost-effective covid vaccine which does not require syringes, needles, alcohol wipes, bandage, etc, saving costs related to procurement,...
Intranasal COVID vaccine: Bharat Biotech to launch iNCOVACC on January 26 MD Bureau23 Jan 2023 5:45 AM GMTINCOVACC is a nasal vaccine indicated for active immunization against SARS-CoV-2 virus infection.
Bharat Biotech founder Dr Krishna Ella bats for incentives, tax breaks for patented products, innovation Ruchika Sharma21 Jan 2023 6:45 AM GMTQueried about the need for three doses of the COVID-19 vaccine instead of just one, Ella said his company was working on the issue.
Delhi High Court makes Bharat Biotech, Centre parties in pleas seeking details on COVID vaccine Covaxin Ruchika Sharma11 Jan 2023 9:26 AM GMTThree petitions challenging the Central Information Commission's (CIC) decision to withhold the facts on the grounds of trade secrets, intellectual...
Bharat Biotech partner Ocugen announces positive top-line data for COVID vaccine Covaxin Ruchika Sharma10 Jan 2023 7:10 AM GMTCOVAXINâ„¢ is a highly purified and inactivated vaccine that is manufactured using a vero cell manufacturing platform.
Bharat Biotech INCOVACC to cost Rs 800 for Private hospitals, Rs 325 for Govt Isra Zaman28 Dec 2022 11:22 AM GMTBharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs...
Health Bulletin 28/December/2022 Isra Zaman28 Dec 2022 11:06 AM GMTHere are the top health stories for the day:Bharat Biotech's iNCOVACC: India's 1st intranasal vaccine to cost Rs 800 in private markets, Rs 325 for...
Bharat Biotech, Biological E together hold about 250 million COVID vaccine doses Ruchika Sharma28 Dec 2022 9:13 AM GMTBharat Biotech sources said the vaccine maker has more than 50 million doses of Covaxin readily available in vials, and over 200 million doses as drug...
COVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for Govt Ruchika Sharma27 Dec 2022 9:00 AM GMTiNCOVACC is the world's first intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose.
Bharat Biotech intranasal COVID vaccine approved by Centre, to be available on CO-WIN Roshni Dhar24 Dec 2022 11:12 AM GMTThe central government has approved the use of Bharat Biotech's nasal Covid vaccine iNCOVACC to be included in the country's vaccination programme as...
Health Bulletin 24/ December/ 2022 Roshni Dhar24 Dec 2022 11:02 AM GMTHere are the top health stories for the day:Fully prepared to deal with any eventuality, say Delhi hospitals amid coronavirus scareAmid concerns over...
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 10:01 AM GMTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
